InvestorsHub Logo
Followers 8
Posts 1379
Boards Moderated 0
Alias Born 03/27/2013

Re: Williams4076 post# 52440

Thursday, 06/25/2015 1:24:06 PM

Thursday, June 25, 2015 1:24:06 PM

Post# of 430324
The document cited is the HHS OIG Data Brief from June 15 discussing questionable billing and potential fraud in Med Part D.

http://oig.hhs.gov/oei/reports/oei-02-15-00190.pdf

On Pg 8 is the commentary about Vascepa and Lovaza. Shows a total misunderstanding of the nature of prescription Omega 3s. Suggests that OTC Omega-3 supplements could be used instead of prescription. Dear God.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News